The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
Cathy - England: Tumefactive Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Linda Elsegood: I'd like to introduce Kathy from England who takes LDN for TMS, which is tumefactive multiple sclerosis. Thank you for joining me, Kathy.
Cathy: Thank you.
Opioid antagonists as potential therapeutics for ischemic stroke
Prog Neurobiol
November 2009
https://pubmed.ncbi.nlm.nih.gov/31398359/#
Dickson Chemist developed a new formulation of LDN which will hopefully improve the outcomes for patients. This new formulation is a more concentrated liquid in the form of drops which are administered under the tongue and absorbed directly from the mucosal lining of the mouth. This sublingual route produces a more rapid absorption bypassing the liver and digestive tract. There are several potential advantages to this, the drug may be more effective and will not be affected by the presence of food stuffs or the hostile environment of the gut.